Methods and compositions for treating edema refractory to oral diuretics
US12329731B2 · kind B2 · utility
0Cited by
4References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 2024 |
| Grant date | Jun 17, 2025 |
| Priority date | — |
| Expiry date | Oct 15, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention features methods and compositions for the intranasal, sublingual, and subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.